 PITTSBURGH, Nov. 23, 2022 GLOBE NEWSWIRE -- Krystal Biotech, Inc. the Company NASDAQ: KRYS a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that the Company will participate in the Evercore ISI 5th Annual HealthCONx Conference, which is taking place virtually from November 29-December 1. 